ABSTRACT
The social value of pharmaceutical marketing is the focus of this discussion. The structure of the pharmaceutical environment is delineated as a transvection system. The proposed framework originates in the product concept and identifies various stages that serve to refine the product concept knowledge to a level of accuracy that is deemed to be safe in the final stage of the process, the consumption of the final product. Marketing-relevant steps are identified and discussed in terms of their social value. This approach to examining the social value of the process affords a level of abstraction that on the one hand is fairly simple yet allows the consideration of multiple perspectives. This discourse stresses the fact that the value of the system is not merely realized from the positive effects harnessed through the system but is the net effect that is realized from a social perspective after accounting for negative effects. The task of identifying the social value of pharmaceutical marketing is as complex as its extent; hence, this discussion adopts a multifaceted perspective that is simple yet allows an efficient discussion of the salient concepts.